IPEC-Americas Announces New Executive Committee Members
IPEC-Americas held elections for executive committee positions at the annual board of trustee’s dinner.
IPEC-Americas hosted their annual board of trustee’s dinner meeting on Dec. 7, 2016 in Arlington, VA. During the meeting the board received reports on IPEC-Americas 2016 accomplishments and ongoing council activities from Priscilla Zawislak, chair.
The group also held elections. Because a quorum was not present, elections took place via email and in person at the meeting. In addition to elections, a proposed 2017 budget was approved. The following are the results for the Executive Committee positions:
Chair Elect
Janeen Skutnik-Wilkinson, Compliance & Standards, Biogen
Vice Chair for Administrative Affairs
Bretta Lichtenhan, Regulatory Surveillance and Advocacy, Global Regulatory Management, MilliporeSigma
Vice Chair Harmonization and Compendial Monograph
Phyllis Walsh, associate director, Merck & Company, Inc.
Elected Executive Committee Members
George Collins Jr., vice-president, Vanderbilt Mineral Co.
Heather Sturtevant, manager, Technical Operations, Johnson & Johnson Consumer Inc.
Meera Raghuram, manager, Regulatory Affairs & Strategies, Lubrizol Advanced Materials, Inc.
Source: IPEC-Americas
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
